Clinical Trial Detail

NCT ID NCT02157103
Title A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.